GR3017868T3 - Spiro dibenzosuberane derivatives. - Google Patents

Spiro dibenzosuberane derivatives.

Info

Publication number
GR3017868T3
GR3017868T3 GR950402972T GR950402972T GR3017868T3 GR 3017868 T3 GR3017868 T3 GR 3017868T3 GR 950402972 T GR950402972 T GR 950402972T GR 950402972 T GR950402972 T GR 950402972T GR 3017868 T3 GR3017868 T3 GR 3017868T3
Authority
GR
Greece
Prior art keywords
alkyl
hydrogen
derivatives
dibenzosuberane
spiro
Prior art date
Application number
GR950402972T
Other languages
English (en)
Inventor
Hiromu Matsumura
Makoto Adachi
Toshisada Yano
Hiroshi Hashizume
Masami Eigyo
Akira Matsushita
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of GR3017868T3 publication Critical patent/GR3017868T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
GR950402972T 1990-05-07 1995-10-25 Spiro dibenzosuberane derivatives. GR3017868T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11812690 1990-05-07

Publications (1)

Publication Number Publication Date
GR3017868T3 true GR3017868T3 (en) 1996-01-31

Family

ID=14728685

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402972T GR3017868T3 (en) 1990-05-07 1995-10-25 Spiro dibenzosuberane derivatives.

Country Status (10)

Country Link
EP (1) EP0456183B1 (el)
JP (1) JPH04225953A (el)
KR (1) KR910019978A (el)
AT (1) ATE128705T1 (el)
CA (1) CA2040750A1 (el)
DE (1) DE69113505T2 (el)
DK (1) DK0456183T3 (el)
ES (1) ES2080182T3 (el)
GR (1) GR3017868T3 (el)
HU (1) HUT58057A (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538986A (en) * 1993-12-06 1996-07-23 Schering Corporation Tricyclic derivatives, compositions and methods of use
US5760246A (en) * 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
AU2003228674A1 (en) 2002-04-26 2003-11-10 Schering Corporation Muscarinic antagonists
US7101917B2 (en) 2003-04-14 2006-09-05 Hoffmann-La Roche Inc. Mitochrondrial permeability transition pore affinity labels and modulators
ES2563304T3 (es) 2003-04-24 2016-03-14 Incyte Holdings Corporation Derivados azaespiro alcano como inhibidores de metaloproteasas
WO2006104594A2 (en) * 2005-02-25 2006-10-05 Irm Llc Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
WO2012169014A1 (ja) 2011-06-07 2012-12-13 パイオニア株式会社 インピーダンス整合装置、制御方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719199D0 (en) * 1987-08-13 1987-09-23 Merck Sharp & Dohme Chemical compounds

Also Published As

Publication number Publication date
CA2040750A1 (en) 1991-11-08
EP0456183A3 (en) 1992-04-22
EP0456183A2 (en) 1991-11-13
EP0456183B1 (en) 1995-10-04
HUT58057A (en) 1992-01-28
DE69113505T2 (de) 1996-04-04
DE69113505D1 (de) 1995-11-09
DK0456183T3 (da) 1995-11-20
KR910019978A (ko) 1991-12-19
ES2080182T3 (es) 1996-02-01
HU911520D0 (en) 1991-11-28
ATE128705T1 (de) 1995-10-15
JPH04225953A (ja) 1992-08-14

Similar Documents

Publication Publication Date Title
HU9600452D0 (en) Compounds avaiable for preparation of isoxazole-derivatives
DE69815700D1 (en) Tetrahydro gamma-carboline
EP0456183A3 (en) Spiro dibenzosuberane derivatives
CA2135783A1 (en) Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation
IL125982A0 (en) 2-(arylphenyl) amino-imidazoline derivatives
ATE223411T1 (de) 1-methylcarbapenem-derivate
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
PL312471A1 (en) Benzene derivatives effective in ischaemia diseases
DK0420224T3 (da) Anthihepatopatisk middel
TW275629B (el)
TW208000B (el)
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.